APA

Julius J. M., Hammerstrom A., Wei C., Rajesh R., Bodurka D. C., Kurian S. & Smith J. A. (20170606). Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Chicago

Julius Justin M, Hammerstrom Aimee, Wei Caimiao, Rajesh Raeshmma, Bodurka Diane C, Kurian Shiney and Smith Judith A. 20170606. Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Harvard

Julius J. M., Hammerstrom A., Wei C., Rajesh R., Bodurka D. C., Kurian S. and Smith J. A. (20170606). Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

MLA

Julius Justin M, Hammerstrom Aimee, Wei Caimiao, Rajesh Raeshmma, Bodurka Diane C, Kurian Shiney and Smith Judith A. Defining the impact of the use of granulocyte colony stimulating factors on the incidence of chemotherapy-induced neutropenia in patients with gynecologic malignancies. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20170606.